CAMBRIDGE, Mass.--(BUSINESS WIRE)--Cognito Therapeutics, a clinical-stage neurotechnology company pioneering neuromodulation-based treatments for neurodegenerative diseases, announced five new poster ...

Amazon Web Services (AWS) has announced updates to Amazon Cognito, its identity and access management service for Web and mobile applications. The service allows developers to secure ...

As a self-proclaimed lifelong learner and former educator, Amy Boyington is passionate about researching and advocating for learners of all ages. For over a decade, Amy has specialized in writing ...

The Seattle-based battle between Amazon and Microsoft for dominance of the cloud services industry has been competitive for a long time. After all, Amazon CEO Andy Jassy helped create the cloud ...

Just as a new wave of approved drugs for Alzheimer’s disease reaches patients, medical device company Cognito Therapeutics has raised a fresh $35 million to advance its alternative treatment for the ...

As it plows ahead in its efforts to secure an FDA greenlight for its light- and sound-based neuromodulation device to treat Alzheimer’s disease, Cognito Therapeutics is taking an even closer look at ...

Cognito Therapeutics has spent the better part of the last decade developing neuromodulation technology that it claims could stop and even reverse the progression of Alzheimer’s and other ...

The AWS Management Console lets you access all your cloud services. Billing and security features are also found on the AWS console. For hands-on support, you can open a case with AWS Support and chat ...